GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis

Journal:

Science Advances

Published:

2025-12-19

DOI:

10.1126/sciadv.adv1434

Affiliations:

3

Authors:

7

Go to article

Institutions	Authors	Share
UCL Queen Square Institute of Neurology, United Kingdom (UK)	3.666667	0.52
Royal Veterinary College, University of London (RVC), United Kingdom (UK)	2.666667	0.38
Aligning Science Across Parkinson's (ASAP), United States of America (USA)	0.666667	0.10

Interested in Neurosciences?